These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2931047)
1. Pharmacokinetics of three oral formulations of ciprofloxacin. Davis RL; Koup JR; Williams-Warren J; Weber A; Smith AL Antimicrob Agents Chemother; 1985 Jul; 28(1):74-7. PubMed ID: 2931047 [TBL] [Abstract][Full Text] [Related]
2. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
3. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers. Gonzalez MA; Uribe F; Moisen SD; Fuster AP; Selen A; Welling PG; Painter B Antimicrob Agents Chemother; 1984 Nov; 26(5):741-4. PubMed ID: 6517556 [TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs. Papich MG Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062 [TBL] [Abstract][Full Text] [Related]
5. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers. Wingender W; Graefe KH; Gau W; Förster D; Beermann D; Schacht P Eur J Clin Microbiol; 1984 Aug; 3(4):355-9. PubMed ID: 6489326 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ciprofloxacin in cystic fibrosis. Davis RL; Koup JR; Williams-Warren J; Weber A; Heggen L; Stempel D; Smith AL Antimicrob Agents Chemother; 1987 Jun; 31(6):915-9. PubMed ID: 3619423 [TBL] [Abstract][Full Text] [Related]
8. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics. Bramer SL; Forbes WP Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses. Bergan T; Thorsteinsson SB; Kolstad IM; Johnsen S Eur J Clin Microbiol; 1986 Apr; 5(2):187-92. PubMed ID: 2941278 [TBL] [Abstract][Full Text] [Related]
10. Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension. Shah A; Liu MC; Vaughan D; Heller AH J Antimicrob Chemother; 1999 Mar; 43 Suppl A():49-54. PubMed ID: 10225572 [TBL] [Abstract][Full Text] [Related]
11. Bioavailability and pharmacokinetics of oral ofloxacin formulations in normal subjects. Stein GE; LeBel M; Flor SC; Zinny M Curr Med Res Opin; 1991; 12(8):479-84. PubMed ID: 1764952 [TBL] [Abstract][Full Text] [Related]
12. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets. Coupez R; Straetemans R; Sehgal G; Stockis A; Lu ZS J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473 [TBL] [Abstract][Full Text] [Related]
13. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects. Khan MK; Khan MF Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and relative bioavailability of prajmalium bitartrate after single oral dosing. Breuel HP; Weimann HJ; Dahmen W; Hausleiter HJ; Bondy S Arzneimittelforschung; 1991 Dec; 41(12):1222-5. PubMed ID: 1815520 [TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability study of cefixime administered as tablets or aqueous solution. Montay G; Masala F; Le Roux Y; Le Liboux A; Uhlrich J; Chassard D; Thebault JJ; Roche G; Frydman A Drugs; 1991; 42 Suppl 4():6-9. PubMed ID: 1725153 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ciprofloxacin in elderly subjects. LeBel M; Barbeau G; Bergeron MG; Roy D; Vallée F Pharmacotherapy; 1986; 6(2):87-91. PubMed ID: 2940518 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Höffken G; Lode H; Prinzing C; Borner K; Koeppe P Antimicrob Agents Chemother; 1985 Mar; 27(3):375-9. PubMed ID: 3158275 [TBL] [Abstract][Full Text] [Related]
18. Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: saliva as a surrogate of pharmacokinetics in the central compartment. Cawello W; Bökens H; Nickel B; Andreas JO; Halabi A Epilepsia; 2013 Jan; 54(1):81-8. PubMed ID: 23148731 [TBL] [Abstract][Full Text] [Related]
19. Multiple-dose ciprofloxacin kinetics in normal subjects. Aronoff GE; Kenner CH; Sloan RS; Pottratz ST Clin Pharmacol Ther; 1984 Sep; 36(3):384-8. PubMed ID: 6467798 [TBL] [Abstract][Full Text] [Related]
20. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]